Liquidia Corp 4

Dr. Stephen M. Bloch (Canaan VIII L.P.) indirectly sold 75,000 shares of Liquidia Corp (LQDA) common stock in open‑market transactions totaling about $6.0 million on July 6–7, 2026.

On July 6–7, 2026, reporting person Dr. Stephen M. Bloch, in his capacity related to the Canaan VIII L.P. venture fund, reported three open‑market sales of Liquidia Corp (LQDA) common stock totaling 75,000 shares at weighted average prices between approximately $80.18 and $81.31 per share, for aggregate proceeds of roughly $6.0 million. These sales reduced the indirect holdings reported under his name from 855,073 shares to 780,073 shares, while he continues to disclaim beneficial ownership of the Canaan entities’ securities beyond any pecuniary interest. The trades were executed in multiple smaller transactions within narrow price ranges, as disclosed in the footnotes, and are characterized as indirect, fund‑level portfolio management rather than personal discretionary selling by the individual insider.

Filing Facts

CIK

1819576

Ticker

LQDA

Form

4

Source Type

fda

Accession

0001104659-26-081808

Alert Tier

7